Analyst Ratings for Mednax Inc. (MD)

Updated: 2017-07-26

Shares of Mednax Inc. (NYSE:MD) have received a consensus rating of Hold from Wall Street analysts. A consensus rating of Hold was previously issued for MD last month.

Of the 14 analysts covering the stock, 2 gave it a buy rating, 0 gave an overweight rating, 11 issued a hold rating, 1 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Investment analysts gave a few price targets for MD. The maximum price target given was 68, which equates to a potential upside of 20.06 percent. The most pessimistic analyst gave a price target of 53, implying a possible loss of -6.43 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

Analysts have revised their earnings estimates upwards for this quarter, by about 0 percent on average, compared to last month. That number becomes -16.86 percent if we expand the time horizon to include the past 3 months instead of just one. On the other hand, earnings estimates for the fiscal year have been revised downwards by -0.72 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -13.41 percent.

People are often interested in whether analysts were united in the direction of their revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, which can be compared to the 0 analysts that decreased their estimates. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, compared to 2 analysts that revised their FY estimates downwards.

MD has an estimated earnings growth rate of -1.81 percent as forecasted by analysts. People on Wall Street often look at a company's PEG ratio. Smaller PEG ratios are desirable, because that is often interpreted as the company being fairly priced relative to its growth rate. Wall Street investors typically prefer a PEG ratio to be smaller than 1, although it is frequently more appropriate to compare PEG ratios to the company's peers. The PEG ratio of MD is -9.31.

In the trailing 52-weeks, MD hit 75.83 at the highest peak, while it's lowest trading point was 53.80. Currently the stock is 5.28 percent higher than its low, and below the high by 25.31 percent. MD has a price/earnings ratio of 16.86. Investors typically compare the P/E ratio to a company's peers in the industry. The MD value stock report compares MD to some of its peers using value stock charts. The market cap of MD is $5.33 billion. MD is estimated to release their earnings results for the quarter on 0000-00-00, days from today.